ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

ARS Pharmaceuticals, Inc.

Ars Pharmaceuticals, Inc. (($SPRY)) has held its Q2 earnings call. Read on for the main highlights of the call. Ars Pharmaceuticals’ latest earning...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SPRY	$4.15	-0.36%	1.87M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SPRY	$4.15	-0.4%	1.87M
3
4
5
6

SPRY

Get ARS Pharmaceuticals, Inc. Data in Excel

Get ARS Pharmaceuticals, Inc. Data in Excel